136 related articles for article (PubMed ID: 8583329)
1. Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression.
Martinez DA; O'Dorisio MS; O'Dorisio TM; Qualman SJ; Caniano DA; Teich S; Besner GE; King DR
J Pediatr Surg; 1995 Nov; 30(11):1580-9. PubMed ID: 8583329
[TBL] [Abstract][Full Text] [Related]
2. Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
Hofland LJ; Breeman WA; Krenning EP; de Jong M; Waaijers M; van Koetsveld PM; Mäcke HR; Lamberts SW
Proc Assoc Am Physicians; 1999; 111(1):63-9. PubMed ID: 9893158
[TBL] [Abstract][Full Text] [Related]
3. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Siehler S; Seuwen K; Hoyer D
Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
[TBL] [Abstract][Full Text] [Related]
4. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Breeman WA; Lamberts SW
Endocrinology; 1995 Sep; 136(9):3698-706. PubMed ID: 7649075
[TBL] [Abstract][Full Text] [Related]
5. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
De Jong M; Bakker WH; Breeman WA; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt M; Béhé M; Mäcke HR; Krenning EP
Int J Cancer; 1998 Jan; 75(3):406-11. PubMed ID: 9455802
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
Siehler S; Seuwen K; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):488-99. PubMed ID: 10598788
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
Breeman WA; de Jong M; Bernard B; Hofland LJ; Srinivasan A; van der Pluijm M; Bakker WH; Visser TJ; Krenning EP
Anticancer Res; 1998; 18(1A):83-9. PubMed ID: 9568060
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
Thoss VS; Piwko C; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe.
Schirmer WJ; O'Dorisio TM; Schirmer TP; Mojzisik CM; Hinkle GH; Martin EW
Surgery; 1993 Oct; 114(4):745-51; discussion 751-2. PubMed ID: 8211689
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
[TBL] [Abstract][Full Text] [Related]
12. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
13. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of somatostatin analogues in paediatric oncology.
Albers AR; O'Dorisio MS
Digestion; 1996; 57 Suppl 1():38-41. PubMed ID: 8813466
[TBL] [Abstract][Full Text] [Related]
15. Characterization of somatostatin receptors on human neuroblastoma tumors.
O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
[TBL] [Abstract][Full Text] [Related]
16. Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
Breeman WA; Hofland LJ; Bakker WH; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1993 Nov; 20(11):1089-94. PubMed ID: 7904561
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
de Jong M; Breeman WA; Bakker WH; Kooij PP; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt MA; Erion JL; Bugaj JE; Mäcke HR; Krenning EP
Cancer Res; 1998 Feb; 58(3):437-41. PubMed ID: 9458086
[TBL] [Abstract][Full Text] [Related]
18. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
[TBL] [Abstract][Full Text] [Related]
19. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
20. Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
De Jong M; Bernard BF; De Bruin E; Van Gameren A; Bakker WH; Visser TJ; Mäcke HR; Krenning EP
Nucl Med Commun; 1998 Mar; 19(3):283-8. PubMed ID: 9625504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
